Clever Leaves and Biopharmaceutical Research Company to Partner for Landmark Cannabis Research Study in Collaboration with the University of California, Davis

NEW YORK, July 27, 2021 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S., today announced a joint partnership with the intent to study the DNA sequence variation of three Clever Leaves’ cannabis cultivars as part of their Project Change Lives campaign.

America’s Pot Labs Have A THC Problem

Keegan Skeate was working the night shift when he first heard about the scam. The 26-year-old was only a few months into his new job at Praxis Laboratory, a Washington state lab that conducts consumer safety tests and THC potency analysis for legal cannabis products. During one quiet shift in 2018, a fellow lab technician walked over to Skeate and told him that she thought someone was manipulating her test results. She said that the numbers in her spreadsheets looked irregular and the recorded THC potency values were higher than she remembered measuring.

UC Davis Professor Once Again in Annual Cannabis Scientist Power List

For the second year in a row, UC Davis Professor of Chemistry Don Land has been recognized as a top influencer in cannabis analysis on the Power List published by The Cannabis Scientist, a cannabis industry publication.  

The Power List is a celebration of cannabis scientists in the areas of cultivation, processing, testing and medicine, and this year is comprised of the five top scientists in five areas:

Counties With More Cannabis Dispensaries Show Reduced Opioid Deaths

A UC Davis study has found that counties with cannabis dispensaries experienced lower mortality rates for opioid use, which suggests alternative pain management could improve health outcomes. Click here for the full story by Karen Nikos-Rose on the UC Davis News website. 

UC Davis submits 19 proposals to the BCC RFP

Despite a tight turnaround time of only 32 days from initial announcement to submission deadline, and restrictions in the California Bureau of Cannabis Control RFP that disallowed several areas of UC Davis research strength, such as hemp cultivation, UC Davis researchers submitted a whopping 19 proposals in response to the call.

UC Davis Cannabis and Hemp Research Forums

Hosted by the Cannabis and Hemp Research Center, the UC Davis Cannabis and Hemp Research Forums are a monthly series of webinars and (post COVID-19) seminars intended to inform our campus community, members of the cannabis and hemp industry, and the general public on cannabis and hemp research being done at UC Davis and also to provide an opportunity for guest external researchers to share their expertise.

State of California Offers Prop 64 Research Funding to Public Universities

The Bureau of Cannabis Control announced on September 17, 2020 a Request for Proposals (RFP) for university research grants for public universities in California. The Bureau has $30 million to be disbursed for research projects related to the implementation and effect of Proposition 64.

The Return of Hemp Research

This August 17, 2020 article in Organic Farmer, subtitled "Western Universities Rekindle Land-Grant Research Programs for Hemp," describes hemp research at both UC Davis and Oregon State University.